California R&D tax credit: 15%, incremental, and forever

California pairs one of the most generous state research credit designs with one of the least forgiving computations. As of mid-2026, the credit is 15% of California-sourced qualified research expenses (QREs) over a base amount — a regular-method-style structure with no analog to the federal alternative simplified credit — plus a basic-research component for corporate payments to qualified organizations. Unused credits carry forward indefinitely; there is no carryback, no refundability, and no transfer. State legislatures revise credit statutes routinely, so verify current parameters with the Franchise Tax Board before relying on any figure here.

Rate, base, and conformity

California borrows the Section 41 definitions of qualified research and QREs — the four-part test travels intact — but applies them only to research performed in California and runs its own machine on top. The computation mirrors the federal regular method: a fixed-base percentage applied to average annual gross receipts, a minimum base of 50% of current-year QREs, and the 15% rate on the increment. Two divergences matter in practice. First, no ASC: federal ASC filers must still assemble a regular-method-style California computation, including historical data many of them stopped maintaining federally. Second, California's definition of gross receipts for the base is narrower than the federal one — generally receipts from sales of real or tangible personal property delivered in California — which can shrink the base dramatically for service and software companies and, counterintuitively, enlarge the credit. That quirk is well known to the FTB, and positions built on aggressive gross-receipts interpretations draw attention.

California conforms to the Code on a fixed-date basis, so federal amendments do not flow through automatically; the credit's permanence and structure are creatures of California law, not federal conformity.

Monetization: indefinite carryforward, nothing else

The credit offsets California franchise or income tax and, for unused amounts, carries forward without limit. There is no carryback, no refund, and no sale. For a loss-running startup this is a deferred asset with real option value — unlike states with 5- or 10-year cliffs, California credits wait indefinitely for profitability — but it is not cash, and credit-limitation years (California has suspended or capped credit usage during past budget crunches) can push utilization out further. S corporation shareholders take a reduced pass-through amount under California's S corporation rules.

The comparison that matters for planning is federal versus state on the same research dollar, as of mid-2026:

Who benefits, and filing mechanics

The credit is most valuable to companies with substantial, growing California R&D headcount and current or foreseeable California tax — the incremental base means flat spenders earn less, and nonrefundability means loss companies wait. The claim rides on Form FTB 3523 with the return; no pre-application is required. Wage sourcing is the load-bearing schedule: for hybrid and remote engineers, California QREs are the wages for services performed in California, and the multistate sourcing discipline applies with force.

The trap: FTB scrutiny

The Franchise Tax Board runs one of the most active research-credit examination programs of any state. Recurring battlegrounds: contemporaneous documentation tying wages to qualified activities (California examiners are unenthusiastic about survey-only studies), the gross-receipts definition in the base, sourcing of wages for travel-heavy employees, and funded-research exclusions on customer contracts. Build the California file to a higher documentary standard than the federal one, not a lower one, and expect the exam cycle to run long.

For how California's design compares dimension-by-dimension with other states, see how state credits differ; for the federal foundation, see what the R&D credit is.